<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67221">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02026739</url>
  </required_header>
  <id_info>
    <org_study_id>ZSHTA2013001</org_study_id>
    <nct_id>NCT02026739</nct_id>
  </id_info>
  <brief_title>The Optimal Intraoperative Supplemental Oxygen Administration During Minimally Invasive Esophagectomy</brief_title>
  <official_title>The Impact of Different Intraoperative Supplemental Oxygen Administration on the Pulmonary Function Following Minimally Invasive Esophagectomy: A Prospective Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tan, Lijie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study hypothesized that a relative low oxygen concentration (40%) supplemental would be
      advantageous to protect the pulmonary function of patients, comparied with conventional high
      oxygen concentration (80%). Therefore we raise this prospective randomized controlled
      research.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients underwent minimally invasive esophagectomy in Zhongshan Hospital of Fudan
      University will be enrolled and be randomizedly assigned to low oxygen concentration (40%)
      supplemental or high oxygen concentration(80%) supplemental group. Intra-operative and
      post-operative pressure of Oxygen in Arterial Blood will be examined, and the surgical
      outcome will be recorded in the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The change of oxygenation index</measure>
    <time_frame>Change from Baseline at post-operative Day1</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The change of oxygenation index is an important index to indicate the pulmonary function of patients.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Oxygenation Index</condition>
  <arm_group>
    <arm_group_label>low supplemental oxygen concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The group in which low supplemental oxygen concentration of 40% will be performed during minimally invasive esophagectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>high supplemental oxygen concentration (conventional)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The group in which high supplemental oxygen concentration (onventional) of 80% will be performed during minimally invasive esophagectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>low supplemental oxygen concentration</intervention_name>
    <description>low supplemental oxygen concentration would be used during the surgery</description>
    <arm_group_label>low supplemental oxygen concentration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>high supplemental oxygen concentration (conventional)</intervention_name>
    <description>high supplemental oxygen concentration would be used during the surgery</description>
    <arm_group_label>high supplemental oxygen concentration (conventional)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinical Staged T1-3N0M0 esophageal cancer patients or: patients who were restaged as
             T1-3N0M0 esophageal cancer after neo-adjuvant therapy.

          2. Patients underwent minimally invasive esophagectomy(Thoracolaparoscopic McKeown
             procedure).

        Exclusion Criteria:

          1. Patients with previous thoracic surgery history.

          2. Patients with severe Co-morbidity.

          3. Pulmonary function is abnormal in the examination before surgery.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lijie Tan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hao Wang, MD</last_name>
    <phone>+86-21-64041990</phone>
    <phone_ext>2914</phone_ext>
    <email>wang.hao@zs-hospital.sh.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hao Wang, MD</last_name>
    <email>wanghao6611@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Thoracic Surgery &amp; Anesthesiology, Zhongshan Hospital of Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hao Wang, MD</last_name>
      <email>wang.hao@zs-hospital.sh.cn</email>
    </contact>
    <contact_backup>
      <last_name>Fang Fang, MD</last_name>
      <email>fang.fang@zs-hospital.sh.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Jing Cang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fang Fang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 31, 2013</lastchanged_date>
  <firstreceived_date>October 31, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Tan, Lijie</investigator_full_name>
    <investigator_title>Professor of Surgery; Vice Chief, Division of Thoracic Surgery</investigator_title>
  </responsible_party>
  <keyword>minimally invasive esophagectomy; pulmonary function</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
